Selected new reviews and commentaries, 2 March 2009

2 March 2009

Mutation Patterns in the Human Genome: More Variable Than Expected.
Duret L (2009) PLoS Biol 7(2): e1000028 doi:10.1371/journal.pbio.1000028
 

Pharmacogenomics - ready for prime time?

Shurin SB, Nabel EG. N Engl J Med. 2008 Mar 6;358(10):1061-3.

Beyond odds ratios - communicating disease risk based on genetic profiles.
Kraft P, Wacholder S, Cornelis MC et al. Nat Rev Genet. 2009 Feb 24. [Epub ahead of print].

The new age of molecular diagnostics for microbial agents.
Whitley R. N Engl J Med. 2008 Mar 6;358(10):988-9. Epub 2008 Feb 6.

Getting to the heart of proteomics.
Ping P. N Engl J Med. 2009 Jan 29;360(5):532-4.

Systems biology. Attractors and democratic dynamics.
Bar-Yam Y, Harmon D, de Bivort B. Science. 2009 Feb 20;323(5917):1016-7.

Molecular biology: The long and short of RNAs.
Carninci P. Nature. 2009 Feb 19;457(7232):974-5.

Alzheimer's disease: A prion protein connection.
Cisse M, Mucke L. Nature. 2009 Feb 26;457(7233):1090-1.

Long non-coding RNAs: insights into functions.
Mercer TR, Dinger ME, Mattick JS. Nat Rev Genet. 2009 Mar;10(3):155-9.

Nucleosome positioning and gene regulation: advances through genomics.
Jiang C, Pugh BF. Nat Rev Genet. 2009 Mar;10(3):161-72.

Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations.
Bateman JF, Boot-Handford RP, Lamandé SR. Nat Rev Genet. 2009 Mar;10(3):173-83.

Pharmacogenetics - tailoring treatment for the outliers.
Woodcock J, Lesko LJ. N Engl J Med. 2009 Feb 19;360(8):811-3.

Metabolic enzymes as oncogenes or tumor suppressors.
Thompson CB.N Engl J Med. 2009 Feb 19;360(8):813-5.

Darwin 200: Human nature: the remix.
Jones D. Nature. 2009 Feb 12;457(7231):780-3.

More from us